DILAWAR AJANI: Open Payments
NPI 1528047115 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 33 payments from 13 companies in 2025. Trend: 2023 $676 · 2024 $785 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $130 |
| Exact Sciences Corporation | 5 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87 |
| Sumitomo Pharma America, Inc. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Dexcom, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $31 |
| Paratek Pharmaceuticals, Inc. | 1 | $30 |
Products named: Cologuard Collection Kit, JARDIANCE, FARXIGA, GEMTESA, AIRSUPRA, Kerendia, Dexcom G6 Transmitter, NEXLETOL.
Industry payments across TX — which companies pay providers there.
